Stroke is a clinically delineated syndrome, which is characterised by an acute, focal neurological deficit resulting from vascular injury (infarction or haemorrhage) within the central nervous system. Notably, around 80 percent of stroke survivors experience post-stroke deficits in upper extremity (UE) motor performance, impacting grip strength, dexterity, and functional independence, which greatly hinder the ability of stroke patients to carry out activities of daily living (ADL), and in turn affects their overall quality of life (QOL).One potential solution to these difficulties is the creation of rehabilitation robotic devices that incorporate hand technology and electrical stimulation. Although soft robotic assistive devices and electrical stimulation have each shown positive effects on motor recovery, their combined use has yet to be thoroughly investigated. This study intends to determine if the simultaneous application of these therapies can speed up rehabilitation results in comparison to independent therapies. Stroke Participants will be divided into two groups, Experimental group and Control group. Both the groups will receive intervention for 40 min/day, 03 days/week, for 08 week and measurements will be taken prior to the treatment, after 4 weeks of treatment and 8 weeks post-treatment.
Age range
45 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Wolf Motor Function Test
Timeframe: Measurements will be taken before the treatment as baseline, after 4 weeks of treatment, and 8 weeks post-treatment
Fugl-meyer assessment of upper limb (FMA-UE)
Timeframe: Measurements will be taken before the treatment, after 4 weeks of treatment, and 8 weeks post-treatment
Nine-Peg Hole Test
Timeframe: Measurements will be taken before the treatment, after 4 weeks of treatment, and 8 weeks post-treatment
Dynamometer
Timeframe: Measurements will be taken before the treatment, after 4 weeks of treatment, and 8 weeks post-treatment
Modified Ashworth Scale
Timeframe: Measurements will be taken before the treatment, after 4 weeks of treatment, and 8 weeks post-treatment.